(Q36342114)

13 August 2017

1 reference

title

Immune reconstitution inflammatory syndrome: more answers, more questions (English)

1 reference

immune reconstitution inflammatory syndrome

13 August 2017

0 references

1 reference

Samuel A Shelburne

1

1 reference

13 August 2017

Martin Montes

series ordinal

2

1 reference

13 August 2017

Richard J Hamill

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

14 December 2005

1 reference

Journal of Antimicrobial Chemotherapy

13 August 2017

1 reference

13 August 2017

57

1 reference

13 August 2017

2

1 reference

13 August 2017

167-170

1 reference

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

13 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Immunorestitution disease involving the innate and adaptive response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

MHC haplotypes affect the expression of opportunistic infections in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

Depletion of regulatory T cells in HIV infection is associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI444

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI444

1 reference

13 August 2017

1 reference